Clinical Trials Directory

Trials / Completed

CompletedNCT04751994

Iron Babies Pilot Supplementation Trial

Enhancing Brain Development by Early Iron Supplementation of African Infants: An Enabling Pilot Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
London School of Hygiene and Tropical Medicine · Academic / Other
Sex
All
Age
6 Weeks – 10 Weeks
Healthy volunteers
Accepted

Summary

2-arm, double blind, placebo controlled, randomised trial, with 50 6-week-old infants per arm randomized to 98 days of daily iron (1.5mg/kg/day as ferrous sulphate) or placebo drops

Detailed description

Healthy infants will be randomised to receive daily supplementation from 6-20wks of either a) iron drops or b) placebo drops. Infants with significant illness or any clinical syndromes that would affect interpretation will be excluded. Low birthweight infants and infants born prematurely will not be excluded. Venous blood samples will be collected at enrollment (age 6 weeks) and after 14 weeks (98 days) of iron/placebo supplementation. Participants will be visited daily in their villages by Fieldworkers (FW) to administer the iron/placebo dose and will interview mothers to complete a short health questionnaire. The iron will be dosed at 75% of WHO guideline dose (ie 1.5mg/kg/day). Weekly, a more detailed morbidity and breastfeeding questionnaires will be administered. Infants will be weighed and measured monthly, along with a faecal sample being taken. During the daily visits, the FWs will record any adverse events (AEs) and ensure the safety of participants. If a child is found unwell or if the mother/guardian reports that the child is unwell, the study nurse will check on the child and decide on treatment/referral to the nearest health centre

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIron drops/Ferrous sulphateparticipant will consume daily drops of iron
DIETARY_SUPPLEMENTPlacebo dropsParticipants will consume daily drops of placebo

Timeline

Start date
2021-08-03
Primary completion
2022-03-09
Completion
2022-03-09
First posted
2021-02-12
Last updated
2022-05-26

Locations

1 site across 1 country: The Gambia

Source: ClinicalTrials.gov record NCT04751994. Inclusion in this directory is not an endorsement.